Astrana Health, Inc. ASTH

Updated: 18 Jun 2026

NASDAQ | Technology | Value-based healthcare technology

No signal published yet

We already track Astrana Health and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Astrana Health free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Technology
Sector
Value-based healthcare technology
We're already tracking Astrana Health, Inc. — here are the latest events we've registered

Recent News

  • In June 2026, Astrana Health was named to the Fortune 1000 list for the first time following significant revenue growth in fiscal year 2025. The company reported Q1 2026 revenue of $965.1 million on May 7, 2026, representing a 56% year-over-year increase. On June 11, 2026, the stock reached a new 52-week high of $39.97.

What Firelda Watch includes for Astrana Health, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Astrana Health, Inc. will be delivered in the same format.

Want to follow Astrana Health, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Astrana Health free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Astrana Health, Inc. ASTH
Astrana Health — follow and we'll monitor it
Follow Astrana Health free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.